Cargando…
Vaccination with inhibin-α provides effective immunotherapy against testicular stromal cell tumors
BACKGROUND: Testicular cancer is the most common male neoplasm occurring in men between the ages of 20 and 34. Although germ-line testicular tumors respond favorably to current standard of care, testicular stromal cell (TSC) tumors derived from Sertoli cells or Leydig cells often fail to respond to...
Autores principales: | Aguilar, Robert, Johnson, Justin M., Barrett, Patrick, Tuohy, Vincent K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394616/ https://www.ncbi.nlm.nih.gov/pubmed/28428886 http://dx.doi.org/10.1186/s40425-017-0237-2 |
Ejemplares similares
-
Targeted Vaccination against Human α-Lactalbumin for Immunotherapy and Primary Immunoprevention of Triple Negative Breast Cancer
por: Tuohy, Vincent K., et al.
Publicado: (2016) -
Inhibin B: are modified ranges needed for orchiectomised testicular cancer patients?
por: Petrozzi, Alessandra, et al.
Publicado: (2019) -
Does inhibin-B help us to confidently refuse diagnostic testicular biopsy in azoospermia?
por: Moradi, Mahmoudreza, et al.
Publicado: (2012) -
Inhibins Tune the Thymocyte Selection Process by Regulating Thymic Stromal Cell Differentiation
por: Carbajal-Franco, Ebzadrel, et al.
Publicado: (2015) -
Serum Inhibin A and Inhibin B Levels in Epithelial Ovarian Cancer Patients
por: Walentowicz, Pawel, et al.
Publicado: (2014)